Drug Profile
Estradiol/levonorgestrel transdermal - Bayer HealthCare Pharmaceuticals
Alternative Names: Climara Pro; Estradiol/levonorgestrel transdermal - Schering AGLatest Information Update: 24 Oct 2021
Price :
$50
*
At a glance
- Originator Bayer HealthCare Pharmaceuticals
- Developer Bayer HealthCare Pharmaceuticals Inc.
- Class Estradiol congeners; Estrenes; Hormonal replacements; Norpregnanes; Small molecules
- Mechanism of Action Estrogen receptor agonists; Progesterone receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed Menopausal syndrome; Postmenopausal osteoporosis
Most Recent Events
- 12 Feb 2019 Chemical structure information added
- 04 Apr 2007 Berlex Inc has been acquired by Bayer HealthCare (MR 9074204)
- 11 Jul 2006 No development reported - Phase-III for Menopausal syndrome in European Union (Transdermal)